Main Session
Sep
30
SH 04 - Gastrointestinal Cancer- Science Highlights
LBA 11 - REDEL Trial: Phase II Trial of Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation
Presenter(s)
Jordan Kharofa, MD - University of Cincinnati, Cincinnati, OH